GNOG vs. BTEE ETF Comparison

Comparison of Global X Genomics & Biotechnology UCITS ETF USD Acc GBP (GNOG) to iShares IV PLC ISH NASDAQ US BTEC UCITS ETF USD DIST (BTEE)

GNOG

Global X Genomics & Biotechnology UCITS ETF USD Acc GBP

GNOG Description

NA

Grade (RS Rating)

Last Trade

£5.62

Average Daily Volume

2,945

Number of Holdings ^*

8

* may have additional holdings in another (foreign) market

BTEE

iShares IV PLC ISH NASDAQ US BTEC UCITS ETF USD DIST

BTEE Description

The Fund seeks to track the performance of the NASDAQ Biotechnology Index (Net Total Return) .

Grade (RS Rating)

Last Trade

£6.09

Average Daily Volume

42,124

Number of Holdings ^*

13

* may have additional holdings in another (foreign) market

Performance

Period	GNOG	BTEE
30 Days	-12.15%	-5.42%
60 Days	-18.72%	-7.15%
90 Days	-5.63%	-4.27%
12 Months	-17.79%	0.96%

6 Overlapping Holdings

	Symbol	Grade	Weight in GNOG	Weight in BTEE	Overlap
	0A3M	F	3.38%	0.94%	0.94%
	0A45	B	5.13%	4.63%	4.63%
	0HI3	F	3.38%	0.31%	0.31%
	0J8Z	F	3.93%	2.15%	2.15%
	0L35	B	4.41%	1.31%	1.31%
	0QZU	C	2.0%	8.04%	2.0%

GNOG Overweight 2 Positions Relative to BTEE

	Symbol	Grade	Weight
	0HAV	C	4.9%
	0RLT	A	4.02%

GNOG Underweight 7 Positions Relative to BTEE

	Symbol	Grade	Weight
	0R1B	C	-3.43%
	0O59	A	-1.48%
	0JAV	A	-0.4%
	0JDK	C	-0.36%
	0RDV	F	-0.08%
	0A3S	C	-0.07%
	0HFR	F	-0.03%

GNOG: Top Represented Industries & Keywords

Industries:

Keywords: Biotechnology Cancer Genomics Genotyping Infectious Diseases Orphan Drugs Rare Diseases Agilent Technologies Analytical Chemistry Asset Management Astrazeneca Biopharmaceutical Cancer Immunotherapy Chemical Pathology Chemistry Chromatography Dna Sequencing Duchenne Muscular Dystrophy Gene Expression Gene Therapy

BTEE: Top Represented Industries & Keywords

Industries:

Keywords: Biotechnology Cancer Alzheimer's Disease Biopharmaceutical Cancer Immunotherapy Infectious Diseases Influenza Malaria Medical Specialties Melanoma Metastatic Non Small Cell Lung Cancer Multiple Sclerosis Organ Systems Orphan Drugs Pancreatic Cancer Rare Diseases Vaccine Alzheimer's Diseases Astrazeneca Clinical Research